Latest News
![](https://panaxia.co.il/wp-content/uploads/2020/07/תמונה-לעמוד-חדשות-פנקסיה-1.png)
Panaxia & Neuraxpharm Launch Medical Cannabis Extracts In Europe, More Products To Come
December 8, 2021 | BENZINGA Medical cannabis producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales
![](https://panaxia.co.il/wp-content/uploads/2021/11/יאהו-תמונה.jpg)
Panaxia recaps 3Q21 with record revenues of 22.5 million, a 34% increase over last year
November 29, 2021 | Yahoo! The company resumed double-digit growth following a decrease in Q2 due to divesting its distribution and logistics operations. Revenues in the
![](https://panaxia.co.il/wp-content/uploads/2020/06/Untitled-design-2020-06-09T110258.323.png)
From vision to reality: Panaxia and Neuraxpharm are the world’s first companies to sell medical cannabis extracts for inhalation in Europe
November 3, 2021 | Yahoo! This week, the first export of medical cannabis extracts for inhalation left Israel to Germany, the largest and fastest-growing medical cannabis
![](https://panaxia.co.il/wp-content/uploads/2021/04/עיצוב-ללא-שם-4-768x432.jpg)
Panaxia continues growth: sums up 1st half of 2021 with 37.3 million revenues, 38.4% growth in comparison to 2020
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd
![](https://panaxia.co.il/wp-content/uploads/2020/06/YAHOO-FINANCE.png)
Panaxia and Neuraxpharm Expands Strategic Collaboration to Poland
August 19, 2021 | Yahoo! The companies signed an agreement for the distribution of advanced medical cannabis-based products in Poland. First sales are expected during H1
![](https://panaxia.co.il/wp-content/uploads/2020/07/MARKET-WATCH.png)
Panaxia & AxioNovo GmbH will market cannabis-based products in Germany
July 29, 2021 | MarketWatch TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire via COMTEX/ — TEL AVIV, Israel and BIELEFELD, Germany, July 29,